Institution statistics

ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM - Netherlands 

Ranking results:

Past rankings:
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2010
Criterium:Position:
Overall Score:800-900
Total Project Funding:91
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):100-200
Partner Constancy:200-300
Project Leadership Index:700-800
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding:400-500
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Networking Rank (Reputation):400-500
Partner Constancy:800-900
Project Leadership Index:300-400
Diversity Index:500-600
2008
Criterium:Position:
Overall Score:200-300
Total Project Funding:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Networking Rank (Reputation):300-400
Partner Constancy:500-600
Project Leadership Index:300-400
Diversity Index:700-800
2007
Criterium:Position:
Overall Score:600-700
Total Project Funding:69
Total Project Funding per Partner:68
Total Number of Projects:100-200
Networking Rank (Reputation):100-200
Partner Constancy:200-300
Project Leadership Index:800-900
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2017-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 58
As coordinator: 5
As participant: 52
Sole participant: 1
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 4.998.104 555.345 1
2015 0 5.369.886 894.981 1
2008 0 27.505.750 1.968.775 6
2007 0 47.032.706 3.011.045 9
2006 0 6.791.095 487.844 3
2005 0 25.182.800 770.258 4
2004 0 40.479.148 1.455.051 6
2003 400.139 3.765.629 655.526 2 2
2002 1.065.727 11.103.937 1.913.435 1 7
2001 3.694.133 9.071.458 1.752.190 2 6
2000 180.000 15.779.336 1.322.969 1 7
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE16
KAROLINSKA INSTITUTE12
MEDICAL RESEARCH COUNCIL11
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE9
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE8
KING'S COLLEGE LONDON8
UNIVERSITY COLLEGE LONDON8
ISTITUTO SUPERIORE DI SANITA7
KATHOLIEKE UNIVERSITEIT LEUVEN7
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR5
THE UNIVERSITY OF MILANO5
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA5
UNIVERSITY OF COPENHAGEN5
AVENTIS PASTEUR4
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
HEALTH PROTECTION AGENCY4
MEDIZINISCHE UNIVERSITAET WIEN4
MUNICIPAL HEALTH SERVICE4
STATENS SERUM INSTITUT4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
UNIVERSITAET REGENSBURG4
UNIVERSITY OF SOUTHAMPTON4
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES3
CENTRE HOSPITALIER UNIVERSITAIRE SAINTPIERRE3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
HOSPITAL UNIVERSITARIO LA PAZ3
HUMBOLDTUNIVERSITAET BERLIN3
INSTITUT PASTEUR3
INSTITUTE OF FOOD RESEARCH3
LEIDEN UNIVERSITY MEDICAL CENTER3
LUND UNIVERSITY3
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS3
NATIONAL BIOLOGICAL STANDARDS BOARD3
RUPRECHT KARLS UNIVERSITAET HEIDELBERG3
THE JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE3
UNIVERSITA DEGLI STUDI DI MILANO3
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II3
UNIVERSITA DEGLI STUDI DI SIENA3
UNIVERSITA DEGLI STUDI DI TRIESTE3
UNIVERSITAET BASEL3
UNIVERSITAETSKLINIKUM AACHEN3
UNIVERSITE LIBRE DE BRUXELLES3
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK3
UNIVERSITY MEDICAL CENTRE UTRECHT3
UNIVERSITY OF AARHUS3
UNIVERSITY OF BIRMINGHAM3
UNIVERSITY OF GENOVA3
UNIVERSITY OF HELSINKI3
UNIVERSITY OF LAUSANE3
UNIVERSITY OF TORINO3
UNIVERSITY OF TURKU3
WAGENINGEN UNIVERSITY3
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
CONSIGLIO NAZIONALE DELLE RICERCHE2
DANMARKS TEKNISKE UNIVERSITET2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
DEUTSCHES PRIMATENZENTRUM2
EUROPEAN AIDS TREATMENT GROUP EV2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO2
FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE2
GENOME RESEARCH2
HOSPICES CANTONAUX CHUV2
HOSPITAL CLINIC BARCELONA2
HOSPITAL UNIVERSITARIO DE LA FE SEVASA2
HOSPITAL UNIVERSITARIO DOCE DE OCTUBRE2
HUNTINGDON LIFE SCIENCES2
INSTITUT CATALA DE LA SALUT2
INSTITUTE OF HEALTH CARLOS III2
INSTITUTO DE SALUD CARLOS III2
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI2
KARL STORZ GMBH & CO KG2
LEIDEN UNIVERSITY2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
LUNDS UNIVERSITET2
MEDICAL UNIVERSITY OF VIENNA2
MEDIZINISCHE HOCHSCHULE HANNOVER2
MEDIZINISCHE UNIVERSITAET INNSBRUCK2
NATIONAL REASEARCH AND SAFETY INSTITUTE FOR THE PREVENTION OF OCCUPATIONAL ACCIDENTS AND DISEASES2
NATIONAL UNIVERSITY OF IRELAND DUBLIN2
NOFIMA MAT AS2
NOGUCHI MEMORIAL INSTITUTE FOR MEDICAL RESEARCH2
ODENSE UNIVERSITY HOSPITAL2
PAEDIATRIC HOSPITAL BAMBINO GESU2
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
ROBERT KOCH INSTITUT2
RUHR UNIVERSITAET BOCHUM2
SANQUIN BLOOD SUPPLY FOUNDATION2
SLASKA AKADEMIA MEDYCZNA W KATOWICACH2
ST GEORGE'S HOSPITAL MEDICAL SCHOOL2
STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK2
STICHTING KATHOLIEKE UNIVERSITEIT MORE PARTICULARLY RADBOUD UNIVERSITY NIJMEGEN MEDICAL CENTRE2
STIFTELSEN SINTEF2
TECHNISCHE UNIVERSITAET MUENCHEN2
Constancy:

Total number of partners:914

Partner loyalty:
Frequent Partner: (> 2 projects): 258
Rare Partner: 656

Frequent / Rare Partner Ratio: 0.39

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES47
RTD HORIZONTAL TOPICS35
SOCIAL AND ECONOMIC CONCERNS25
PROTECTING MAN AND HIS ENVIRON15
AGRICULTURE AND MARINE RESOURC4
MEASUREMENTS AND STANDARDS2
ENERGY1
INDUSTRY AND TECHNOLOGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2017-06-01Program for Innovative Global Prevention of Streptococcus suis. PIGSsparticipant4.998.1049
2015-11-01Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje SEPCELLparticipant5.369.8866
2008-09-01An integrated study on three novel regulatory hubs in megakaryocytes and platelets, discovered as risk genes for myocardial infarction by a genome-wide association and platelet systems biology study NETSIMparticipant2.851.38410
2008-09-01Nanoparticles for therapy and diagnosis of Alzheimer disease NADparticipant10.921.35019
2008-06-01IBD: proteases offer new targets for drug discovery IPODDparticipant2.999.25012
2008-02-01Next generation HIV-1 immunogens inducing broadly reactive neutralising antibodies NGINparticipant7.534.74217
2008-02-01Occupational Health and Safety Economics ECOSHparticipant210.5745
2008-01-01Molecular and cellular investigation of neuron-astroglia interactions: Understanding brain function and dysfunction NEUROGLIAparticipant2.988.4508
2007-07-01Pathogenesis and identification of predictive factors of TB-IRIS in HIV patients under HAART TBIRISparticipant2.475.4827
2007-07-01Contribution of molecular epidemiology and host-pathogen genomics to understand Chlamydial trachomatis disease EPIGENCHLAMYDIAparticipant450.00019
2007-04-01Evolution of the Protein-Interaction Networks: the SH3 network in Yeast PENELOPEparticipant2.900.0007
2007-02-01European AIDS treatment Network NEATparticipant12.500.00041
2007-01-15Pre-clinical studies towards an affordable, safe and efficacious two-component paediatric malaria vaccine PRIBOMALparticipant2.345.3586
2007-01-01Development of an effective RNA interference-based anti-HIV-1 therapy using an SV40-derived gene transfer vector HIVSTOPparticipant2.250.0004
2007-01-01Immune response to respiratory virus infections and vaccination in elderly RESPVIRUSESparticipant1.770.3618
2007-01-01Applied Genomic strategies for treatment and prevention of cardiovascular death in Uraemia and end stage renal disease GENECUREparticipant2.246.00010
2007-01-01European vaccine and microbicides enterprise EUROPRISEparticipant20.095.50539
2006-08-01Improving the safety of blood and organ supply by creating the research infrastructure to monitor emerging pathogens and develop new screening tests BOTIAparticipant2.091.0959
2006-03-01The EuroSIDA Network 2005-2009. Clinical and virological outcome of patients with HIV under care in Europe EUROSIDA 2005-2009participant3.000.00016
2006-03-01Concerted action on seroconversion to AIDS and death in Europe CASCADEparticipant1.700.00025
2005-09-01Global view of food allergy: opportunities to study the influence of microbial exposure GLOFALparticipant413.8148
2005-06-01The prevalence, cost and basis of food allergy across Europe EUROPREVALLparticipant14.329.83868
2005-03-01Reprogramming the immune System for the Establishment of Tolerance RISETparticipant9.781.15026
2005-01-01Challenging the hidden HIV: understanding the block on transcriptional reactivation to eradicate infection HIDDEN HIV CHALLENGEparticipant657.9985
2004-06-01Identification of risk genes for atherothrombosis in coronary artery disease by transcriptome and proteome analysis and high throughput exon resequencing BLOODOMICSparticipant8.879.15414
2004-04-01Platform of information services for the coordination of rare disease research with various stakeholders from research, SMEs and patient organisations and the coordination of early clinical trials ORPHANPLATFORMparticipant400.00018
2004-04-01X-linked Adrenoleukodystrophy (X-ALD): pathogenesis, animal models and therapy X-ALDparticipant1.800.0006
2004-01-01Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe EUROPEAN LEUKEMIANETparticipant6.000.000177
2004-01-01Health promoting, safe seafood of high eating quality in a consumer driven fork-to-farm concept SEAFOODPLUSparticipant14.399.99472
2004-01-01European Vascular Genomics Network EVGNparticipant9.000.00034
2003-12-013D Genome structure and function 3DGENOMEparticipant2.173.8038
2003-01-01Risks of occupational vibration exposures VIBRISKSparticipant1.591.8266
2003-01-01Recommendations for a future instrument for the gendersensitive assessment of health research protocols by research ethics committees (recs). GENDER AND RECScoordinator111.6175
2003-01-01Contrast enhanced ultrasound imaging in the diagnosis and treatment of prostate cancer (contrast). CONTRASTcoordinator288.5223
2002-12-01European vaccine effort against HIV/AIDS - III EUROVAC-IIIparticipant2.500.0009
2002-12-01Refsum's disease: diagnosis, pathology and treatment (RDDPT) RDDPTcoordinator1.065.7274
2002-10-01Evaluation of a therapeutic vaccination strategy for hiv infection (THERAVAC) THERAVACparticipant2.379.6479
2002-09-01Virological characterisation of primary hiv infection in the concerted action on seroconversion to aids and death in europe (CASCADE VIROLOGY) CASCADE VIROLOGYparticipant528.24014
2002-09-01Twin to twin transfusion syndrome and monochorionic twinning european network EURO-TWIN-2-TWINparticipant1.555.4008
2002-09-01Hiv-1 reverse transcriptase inhibitor and its consequences for viral virulence VIRULENCEparticipant1.299.9988
2002-01-01Quality of life following adherence therapy for people disabled by schizophrenia and their carers (QUATRO) QUATROparticipant1.845.4384
2002-01-01Peroxisomal diseases: elucidation of the pathogenesis and evaluation of treatments by using mouse models (MMPD) MMPDparticipant995.2144
2001-12-01Genome-wide structural and functional analysis of sh3-mediated interactions (SH3 GENOMICS) SH3 GENOMICScoordinator1.467.7535
2001-12-01European prediction of psychosis study (EPOS) EPOSparticipant1.891.1884
2001-11-01European vaccine effort against hiv/aids - ii EUROVAC-IIparticipant2.999.99713
2001-10-01Development of standardised blood and a reference procedure for determination of aggregation of blood cells (AGGREGATION STANDARD) AGGREGATION STANDARDparticipant596.0004
2001-09-01Development and clinical study of a bioartificial liver based on reversibly immortalised human hepatocytes BIOARTIFICIAL LIVERcoordinator2.226.3806
2001-09-01The european network for vertically acquired hepatitis c virus infection (EPHN) EPHNparticipant500.00043
2001-01-01Optical methods for medical diagnosis and monitoring of diseases participant1.095.74319
2001-01-01Evaluations and predictions of dermal absorption of toxic chemicals EDETOXparticipant1.988.53012

overview shows latest 50 from 58 projects (2000-01-01 - 2017-12-31)
A full list of projects can be found here:

Alias institution names:
  • ACADEMIC MEDICAL CENTER
  • ACADEMIC MEDICAL CENTER AT THE UNIVERSITY OF AMSTERDAM
  • ACADEMIC MEDICAL CENTER OF THE UNIVERSITY OF AMSTERDAM
  • ACADEMIC MEDICAL CENTER UNIVERSITY OF AMSTERDAM
  • ACADEMIC MEDICAL CENTRE BY THE UNIVERSITY OF AMSTERDAM
  • ACADEMISCH MEDISCH CENTRUM
  • ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSTITEIT VAN AMSTERDAM
  • ACADEMISCH MEDISCH CENTRUM UNIVERSITEIT VAN AMSTERDAM
  • ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM
  • AMSTERDAM MEDICAL CENTER

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: